Skip to content

Brain functional network correlates and predictors of the perioperative antidepressant effect of esketamine in breast cancer patients: a double-blind randomized controlled trial using resting-state fMRI and graph theory.

Huimin Zhu, Qingfeng Wei, Shuang Xu, Yunwei Sun, Xuesheng Liu, Jiajia Zhu, Yongqiang Yu

Transl Psychiatry March 6, 2026 DOI: 10.1038/s41398-026-03929-3 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Double-blind Peer reviewed
Population Breast cancer patients
Intervention Esketamine
Topics Esketamine
Citations 1
Key findings A single preoperative dose of esketamine reduced depressive symptoms in breast cancer patients 24 hours after surgery, an effect associated with and predicted by changes in brain functional connectivity and network properties.

Abstract

Brain functional network correlates and predictors of the perioperative antidepressant effect of esketamine in breast cancer patients: a double-blind randomized controlled trial using resting-state fMRI and graph theory.